Italian Society of Rheumatology Highlights Challenges and Progress in Rare Disease Care
Rare rheumatological diseases present significant diagnostic and therapeutic hurdles in Italy, according to the Italian Society of Rheumatology (SIR). Although acknowledging improvements in national planning and specialized care networks, the SIR emphasizes the need to address diagnostic delays, bureaucratic complexities surrounding access to orphan drugs, and the importance of patient-driven awareness initiatives.
Diagnostic Delays and the Importance of Awareness
A key challenge in managing rare rheumatological diseases is the time it takes to reach a diagnosis. As Professor Marta Moscato, full professor of Rheumatology at the University of Pisa and coordinator of the European network for rare rheumatological diseases ERN ReCONNET, explains, “If you don’t recognize, you don’t recognise.” This underscores the critical need for increased awareness among healthcare professionals and the public.
The rise of social media and patient-led advocacy groups is playing a vital role in bridging this gap. Patients sharing their experiences online helps to raise awareness, reduce feelings of isolation, and expedite the diagnostic process.
National Plan and Specialized Networks
Despite the challenges, the SIR highlights positive developments in the Italian healthcare system. A National Plan dedicated to rare diseases has been implemented, and regional networks have been established, utilizing a ‘hub & spoke’ model to connect patients with specialized care.
Italy is actively integrated within critical European networks, such as ERN ReCONNET, facilitating collaboration and access to expertise across borders. These efforts have resulted in the majority of patients being able to access appropriate care.
Bureaucratic Hurdles and Access to Therapies
However, access to treatment remains a significant obstacle. The SIR points to the bureaucratic complexity associated with obtaining orphan drugs and utilizing off-label medications, which can delay or impede patients from receiving necessary therapies.
SIR and ERN ReCONNET: Key Organizations
The Italian Society of Rheumatology (SIR) serves as a central organization for advancing research, education, and healthcare in rheumatology within Italy. Its secretariat is located in Milan, Italy.
ERN ReCONNET, coordinated by Professor Moscato, is a European network dedicated to improving the care of patients with rare rheumatological diseases.
Looking Ahead
World Rare Disease Day, promoted in Italy by UNIAMO, serves as a crucial reminder of the ongoing challenges and the need for continued progress in rare disease care. The SIR’s assessment provides a valuable snapshot of the current landscape, highlighting both the advancements made and the areas requiring further attention to ensure equitable access to diagnosis and treatment for all patients with rare rheumatological conditions.